Peter G. Pappas
Impact in
- Infectious Diseases top 0.01%
- Antifungal resistance and susceptibility
- Epidemiology top 0.01%
- Fungal Infections and Studies
- Nail Diseases and Treatments
- Pneumocystis jirovecii pneumonia detection and treatment
Papers in
-
- Antifungal resistance and susceptibility 183
- Epidemiology 164
- Fungal Infections and Studies 144
- Nail Diseases and Treatments 36
- Pneumocystis jirovecii pneumonia detection and treatment 26
- Co-authors
- Thomas J. Walsh (23 shared papers)Carol A. Kauffman (38 shared papers)Luis Ostrosky‐Zeichner (27 shared papers)William E. Dismukes (21 shared papers)John Rex (16 shared papers)Annette C. Reboli (12 shared papers)David R. Andes (18 shared papers)John E. Edwards (8 shared papers)
- Journals
- Clinical Infectious Diseases (50 papers)Open Forum Infectious Diseases (27 papers)Journal of Clinical Microbiology (11 papers)Antimicrobial Agents and Chemotherapy (10 papers)Mycoses (8 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Peter G. Pappas
247 papers receiving 31.0k citations
Peter G. Pappas's Hit Papers
Peers
Comparison fields: 5 of 174
- Infectious Diseases 23.8k
- Epidemiology 20.7k
- Applied Microbiology and Biotechnology 1.1k
- Small Animals 1.8k
- Microbiology 126
Countries citing papers authored by Peter G. Pappas
This map shows the geographic impact of Peter G. Pappas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter G. Pappas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter G. Pappas more than expected).
Fields of papers citing papers by Peter G. Pappas
This network shows the impact of papers produced by Peter G. Pappas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter G. Pappas. The network helps show where Peter G. Pappas may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter G. Pappas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 256 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2015 | 2804 |
| 2 | Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2009 | 2512 |
| 3 | Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2010 | 1903 |
| 4 | Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS Hit paper breakdown → | 2009 | 1624 |
| 5 | Guidelines for Treatment of Candidiasis Hit paper breakdown → | 2004 | 1143 |
| 6 | Invasive candidiasis Hit paper breakdown → | 2018 | 1089 |
| 7 | Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2016 | 1046 |
| 8 | Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia Hit paper breakdown → | 1999 | 971 |
| 9 | A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia Hit paper breakdown → | 1994 | 862 |
| 10 | Practice Guidelines for the Treatment of Candidiasis Hit paper breakdown → | 2000 | 751 |
| 11 | A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients Hit paper breakdown → | 2003 | 705 |
| 12 | Anidulafungin versus Fluconazole for Invasive Candidiasis Hit paper breakdown → | 2007 | 670 |
| 13 | Multicenter Clinical Evaluation of the (1->3) -D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans Hit paper breakdown → | 2005 | 555 |
| 14 | Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2008 | 522 |
| 15 | Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis Hit paper breakdown → | 2007 | 511 |
| 16 | 2001 | 490 | |
| 17 | 2003 | 444 | |
| 18 | 1994 | 400 | |
| 19 | 2001 | 390 | |
| 20 | 1992 | 388 |
About Peter G. Pappas
Peter G. Pappas is a scholar working on Infectious Diseases, Epidemiology, Oncology, Cell Biology and Small Animals, having authored 256 papers that have together received 32.8k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (183 papers), Fungal Infections and Studies (144 papers), Nail Diseases and Treatments (36 papers), Pneumocystis jirovecii pneumonia detection and treatment (26 papers), Plant Pathogens and Fungal Diseases (20 papers), Infectious Diseases and Mycology (18 papers), Neutropenia and Cancer Infections (11 papers) and Antibiotic Use and Resistance (8 papers). The work is most often cited by research in Infectious Diseases (23.8k citations), Epidemiology (20.7k citations), Applied Microbiology and Biotechnology (1.1k citations), Small Animals (1.8k citations) and Microbiology (126 citations). Peter G. Pappas has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Thomas J. Walsh, Carol A. Kauffman, Luis Ostrosky‐Zeichner, William E. Dismukes, John Rex, Annette C. Reboli, David R. Andes, John E. Edwards, Jack D. Sobel and José A. Vázquez. Their work appears in journals such as Clinical Infectious Diseases, Open Forum Infectious Diseases, Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Mycoses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.